Herbal standardization - a benign quality marker or a destroyer of phytochemical synergy? European Pharmacopoeia aims to provide quality standards for medicinal substances important for public health in Europe.
Herbal standardization - a benign quality marker or a destroyer of phytochemical synergy? European Pharmacopoeia aims to provide quality standards for medicinal substances important for public health in Europe.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as PPT, PDF, TXT or read online from Scribd
Herbal standardization - a benign quality marker or a destroyer of phytochemical synergy? European Pharmacopoeia aims to provide quality standards for medicinal substances important for public health in Europe.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as PPT, PDF, TXT or read online from Scribd
Elizabeth M Williamson Professor of Pharmacy and Director of Practice
University of Reading
UK delegate to the group of experts (phytochemistry) of the European Pharmacopoeia and
member of the expert advisory group on herbal and complementary medicines to the British Pharmacopoeia Types of herbal extract • Infusions (teas) – often ‘home made’ by patient • Decoctions (made by boiling), fluid extracts and tinctures (made with ethanol and water) – often prepared by herbalist • Essential oils, steam distilled, expressed or solvent extracted – usually commercial • Unstandardized extracts – home made or commercial • Standardized (or ‘normalized’ according to the European Pharmacopoeia) extracts: includes ‘quantified’ and ‘purified’ extracts – commercial General quality control issues • If you grow your own herbs, you know the quality! • If you buy them in, the following may present a problem: – Identity of plant – mistaken identity or substitution – General quality of the plant – depends on climate, processing (drying) etc – Contamination with organic or inorganic material – Spoilage by insect pests or moulds – Content of active constituents – a reasonable range • These are measures of basic quality – and no more than you would expect of food! Identification of the plant species
• Whole plant organs – relatively easy to
identify • Cut herbs – difficult to identify • Final product – almost impossible to identify! The European Pharmacopoeia • ALL THE PREVIOUS TYPES OF PREPARATION CAN BE QUALITY CONTROLLED – e.g. using the methods and standards of the European Pharmacopoeia (Ph. Eur.) • Objectives: to provide quality standards for medicinal substances important for public health in Europe – for all kinds of drugs, including herbals • Scope: covers of all types of herbal preparations, from the fresh or dried plant material to the different types of extract, for purity and quality – not safety or efficacy • Not many extract monographs yet available, but are a priority Pharmacopoeial monographs • Identity of plant or extract: microscopy and thin-layer chromatography • Phytochemical content of plant or extract: assay either colorimetrically or by HPLC. • Limits chosen reflect a range found on a normal, good quality sample: data taken from literature, industry (importers, growers as well as manufacturers) and academia • Test for foreign organic matter (other plant species, unwanted parts of a plant) – e.g. heavy metals or radioactivity from a polluted environment, pesticide residues • – some are very toxic (e.g. Aspergillus niger, which produces aflatoxins), bacteria (e.g. Salmonella, E. coli) • Presence of microbial, heavy metal etc contamination • Approach is pragmatic, and from a public safety point of view - it DOES NOT FAVOUR industry, although their batch data is used and some of their analytical methods Definition of standardization ‘the establishment of reproducible quality by comparing a product with established reference substances and by defining minimum and sometimes maximum concentrations of one or more compounds or groups of compounds’
NB: CRITERIA FOR STANDARDIZATION
based on what is normal for a good quality product – hence the European term ‘NORMALIZATION’ What is (and isn’t) standardization? IT DOES INCLUDE: IT DOES NOT • Combining batches to INCLUDE: give a consistent • The production of product ‘artificial’ extracts • Removing unwanted • The addition of isolated constituents (e.g. fats, substances, whether of proteins, sugars) to natural or synthetic give a more origin – ‘spiking’ concentrated product: • The addition of e.g. soya isoflavones anything not normally • Removing toxic found in the plant constituents to give a if this occurs, it is safer product: FRAUD e.g. butterbur Types of Standardized Extract • Type A: (Truly) standardized to active constituents – senna, standardized to anthraquinones 5.5-8.0% – belladonna, standardized to alkaloids (as hyoscyamine) 0.95-1.05% • Type B: ‘quantified’ – standardized to constituents that contribute to activity – St John’s wort, standardized to hypericin 0.1-0.4% – Ginkgo biloba, standardized to both flavonoids 16-26% and terpene lactones (ginkgolides) 5-7% • Type C: standardized to lead compounds of unknown pharmacological relevance, which serve as quality markers – Artichoke, standardized to 2-5% cynarin – Valerian, standardized to 0.8-1% valerenic acid Purified or refined extracts • Involve a further process of purification, for example removal or minimisation of toxic ingredients: Removal of ginkgolic acids from Ginkgo biloba
• There will soon be two monographs in the Ph.Eur, one
for the normal standardized extract, and one for the purified extract
• Concentration of anthocyanins in bilberry extract:
Contains 32.4-39.6% anthocyanins, and less than 1.0% free anthocyanidins Why standardize? • For reproducibility in any herb • For more potent herbs • For patients to purchase and self-medicate • For enabling a dose regime to be defined • For use in clinical studies (otherwise data considered anecdotal only) • If a preparation is to be marketed as a medicinal product • For compliance with Pharmacopoeial standards - for quality assurance Do you get what you pay for?
Ginkgo Biloba 1,250mg Ginkyo 50mg (30 Tabs)
60 for £1.95 Price: £9.95 Inc VAT 360 for £4.95
no way of knowing! When not to standardize
• When visiting a qualified herbal practitioner
– these are individually made for the patient, and the practitioner knows exactly what they are and where they have come from • When preparing a fresh herbal tea • When no standard is available to measure • If you don’t want to…… Myths about standardization 1.
‘Poor extracts can be spiked with an
active constituent to make them look better’ ………..so let’s look at Ginkgo biloba and Hypericum perforatum Ginkgolide B • Tocris catalogue no 1657 • Cost: £149.00 for 50 mg Hypericin • Tocris catalogue no 1520 • Cost: £45.00 for 1 mg Myths about standardization 2. ‘the majority of advocates of standardization consist of academics and medical doctors who have little personal or clinical experience with herbs’ (Dr M Tierra, Founding member of the American Herbalists Guild….. is he an academic or a medical doctor?!)
………so don’t herbal practitioners care about the
quality of the products they buy? Do they make everything themselves? Don’t they care what’s in them? Don’t they believe that the healing qualities of a herb depends on it’s composition and therefore quality? Silybum marianum analysis comparing flavonoid and phenolic acid profiles of a commercial tincture with one made by a herbalist COMMERCIAL TINCTURE Retention Time FRESH TINCTURE 5.51 & 5.80 Caffeic acid derivative 8.41 Caffeic acid derivative 8.83 & 8.90 p-coumaric acid derivative p-coumaric acid 10.78 Ferulic acid 11.48 Ferulic acid 11.7 p- coumaric acid 12.9 Caffeic acid derivative 13.8 Flavanone Flavanone 14.1 Flavanone 14.8 Flavanone 15.5 Flavanol glycoside 16.6 p-coumaric acid derivative 16.9 Flavanone 17.8 Flavanone 18.8 p-coumaric acid derivative p-coumaric acid derivative 19.1 p-coumaric acid derivative Fresh v commercial tincture Fresh tincture Commercial tincture • Herbalist took the • Previous product was NOT plant and made the standardized tincture • Contains a much narrower range of • The analytical profile actives shows an excellent • Suggests decomposition of many range of antioxidants derivatives to parent compound • Standardization in this • A good standardization would ensure case is unnecessary! derivatives were chosen, not the parent compound (e.g. senna is always standardized to the glycosides, never the parent compound, and the assay ensures this) Myths about standardization 3. ‘the majority of advocates of standardization ….. Are researchers whose work is funded by the companies that manufacture the standardized extracts used in their clinical trials’ M Tierra, Founding member of the American Herbalists Guild Comment: • Quite true, such researchers do advocate using standardized extracts, since clinical trials are very expensive and funding difficult to come by • The value of clinical trial results depends on reproducibility and statistics. If you can’t say exactly what you gave the patient, and the dose that you gave, then the data is not reproducible, unreliable, unacceptable for publication and you may as well not bother doing them. • You won’t get ethics approval anyway………….. Why are herbalists against standardization?
• If compulsory, would prevent them
making their own products (tinctures, ointments etc) • Restriction of professional freedom
• True, but they are never going to be
made compulsory for practitioners
• Misunderstanding as to what they are?
Why are herbalists shouldn’t be against standardization! • Good clinical trial results enhance the status and perception of herbal medicine and of herbalists • Conversely, bad publicity damages everyone involved in herbalism • If you can’t make the preparation yourself, you need to be confident that the product you are using is safe - and will be effective • Standardized products are never going to be made compulsory for practitioners – and it is only possible for certain herbs where the actives are well known Some other standardized extracts • ‘It is of the greatest importance that the blend should never vary from this standard, which customers will have come to expect…..the second aim is, therefore, to achieve consistency’ ‘Whisky web: the art of blending’
• ‘Non-vintage champagne is a blend of
several different years' wine. Because of this, the character of non-vintage champagne is very consistent year after year’ ’www.finewine.com’ Conclusion • Standardization is just another tool for quality control • In preparations standardized to Pharmacopoeial monographs, the analysis will also have been performed – and this will show that the range of constituents is still there! • Therefore, there is no logical reason why standardization should ‘destroy’ synergy – quite the opposite, it should preserve it • However: it is quite easy for any manufacturer to say that their product is standardized……….